1. A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells
   Yingying Peng et al, 2023, Pharmaceutics CrossRef
2. Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer
   Fengyi Mao et al, 2022, The Prostate CrossRef
3. Improving Strategies in the Development of Protein‐Downregulation‐Based Antiandrogens
   Rongyu Zhang et al, 2021, ChemMedChem CrossRef
4. Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential
   Simon Mathien et al, 2021, Pharmacological Reviews CrossRef
5. Exploration of the diagnostic capacity of PSAMR combined with PI-RADS scoring for clinically significant prostate cancer and establishment and validation of the Nomogram prediction model
   Dengke Li et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
6. Advances in the role of heat shock protein 90 in prostate cancer
   Zheng Fu et al, 2022, Andrologia CrossRef
7. Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90
   Alex Henke et al, 2016, Cancers CrossRef
8. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells
   Zhirui Zhang et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef